Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Corticosteroids on Microcirculation in Cardiac Surgery
NCT02798068Phase 4Terminated
- Sponsor
- Erasmus Hospital
- Start
- May 2016
- Primary completion
- Sep 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Systemic Inflammatory Response Syndrome (SIRS) comparing Solu - Medrol with Placebo (2 arms). Primary endpoint: Flow Mediated Vasodilation change at 48 hours. Started May 2016; status: terminated.
02
Drugs
methylprednisolone
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NCT02798068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02798068.